CCN2 and polycystic ovary syndrome: Following treatment, there was an increase in basal expression of CTGF following TGFβ1 1 ng/ml treatment in both myotubes from healthy women (P < 0.05, Figure 6A) and from women with PCOS (P < 0.05, Figure 6A).